Elevance Health Inc. (ELV) Tops Q3 EPS by 37c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Elevance (ELV) PT Raised to $571 at Jefferies
October 20, 2022 8:48 AM EDTJefferies analyst David Windley raised the price target on Elevance (NYSE: ELV) to $571.00 (from $569.00) while maintaining a Buy rating.
The analyst commented, "LV's membership growth continues to be impressive, having eclipsed UNH in total members in the last 12 months. Government growth plus solid... More
